Point72 Hong Kong LTD Adverum Biotechnologies, Inc. Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.34 $535 - $885	-661 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.23 - $1.95 $813 - $1,288	661 New	661 $1,000
Q4 2021 Feb 14, 2022	SELL	$1.74 - $2.4 $4,760 - $6,566	-2,736 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.08 - $3.6 $5,690 - $9,849	2,736 New	2,736 $6,000
Q2 2021 Aug 16, 2021	SELL	$3.36 - $10.56 $7,163 - $22,513	-2,132 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.26 - $14.36 $19,742 - $30,615	2,132 New	2,132 $21,000
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $40,284 - $58,380	-4,094 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $42,168 - $88,594	4,094 New	4,094 $42,000
Q2 2020 Aug 14, 2020	SELL	$8.53 - $25.64 $2,200 - $6,615	-258 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $2,058 - $4,210	258 New	258 $3,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.